Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber and the Jimmy Fund assume no liability for inaccuracies that may result from using this third-party tool, which is for website translation.
Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber and the Jimmy Fund assume no liability for inaccuracies that may result from using this third-party tool, which is for website translation.

Rare and Resistant Cancers

  • The Dana-Farber Campaign: Stopping cancer before it starts

    The Dana-Farber Campaign: Stopping cancer before it starts

    The Dana-Farber Campaign dramatically advanced the prevention, early detection, and interception of cancers on a wide variety of fronts.

    Continue Reading

  • The Dana-Farber Campaign: FDA approves new pediatric brain cancer drug

    The Dana-Farber Campaign: FDA approves new pediatric brain cancer drug

    Support for The Dana-Farber Campaign advanced research leading to approval of the new treatment for pediatric low-grade glioma (PLGA).

    Continue Reading

  • The Cancer Couch Foundation

    The Cancer Couch Foundation

    The Cancer Couch Foundation recently made a gift of $125,000 to support metastatic breast cancer (MBC) research under the direction of Daniel Abravanel, MD, PhD. This gift enables Abravanel and his team to leverage cutting-edge profiling technologies, such as single-cell sequencing and spatial profiling, to develop personalized and effective treatments to combat MBC.

    Continue Reading

  • Carla L. DeSantis

    Carla L. DeSantis

    Carla L. DeSantis established the Robert A. DeSantis Fund for Cancer Research with a gift of $150,000 in memory of her father. With this investment, Brian Wolpin, MD, and his team in the Gastrointestinal Cancer Center are well-positioned to design new clinical trials with the goal of developing more effective therapies for patients with pancreatic…

    Continue Reading

  • International Myeloma Society

    International Myeloma Society

    Mohammad Rashidian, PhD, received The International Myeloma Society and Paula and Rodger Riney Foundation Translational Research Award. He will use his $250,000 grant to empower investigations to address the challenge of disease relapse in patients treated with a specific type of CAR T-cell therapy. Such studies hold great promise in extending the efficacy of this…

    Continue Reading

  • Arthur David Levin

    Arthur David Levin

    With a gift of $100,000, Arthur David Levin established the Andrew John Torino Fund for Esophageal Cancer in honor of a dear friend’s husband, Andrew. This fund will advance the development of a new test to detect circulating tumor DNA (ctDNA) in the blood, with the goal of determining the risk of cancer recurrence in…

    Continue Reading

  • Kevin and Kimberley Mitnick

    Kevin and Kimberley Mitnick

    Kevin and Kimberley Mitnick made a generous gift to support pancreatic cancer research by Srivatsan Raghavan, MD, PhD, before Kevin’s passing from pancreatic cancer in July 2023. This generous contribution reflects their desire to help Dana-Farber uncover new treatment options and improve outcomes for all patients facing pancreatic cancer.

    Continue Reading

  • National Foundation for Cancer Research

    National Foundation for Cancer Research

    The National Foundation for Cancer Research awarded over $300,000 to Dana-Farber’s Kornelia Polyak, MD, PhD, to advance research in metastatic breast cancer. This funding will support her work in treatment resistance in HER2+ breast cancer brain metastases and ultimately help transform the landscape of patient care.

    Continue Reading

  • Researchers support research to advance early detection

    Researchers support research to advance early detection

    Marielle and Angel Kaifer are supporting Dana-Farber research into a blood test to detect and monitor bladder cancers.

    Continue Reading

  • First-ever fellowship in metastatic prostate cancer and AI research

    First-ever fellowship in metastatic prostate cancer and AI research

    Tom and Olivia McDonough's gift fuels collaboration to harness the power of AI and speed development of novel therapies against prostate cancer.

    Continue Reading